AstraZeneca Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 89.75, with a low estimate of 82 and a high estimate of 97. The average target predicts an increase of 29.04% from the current stock price of 69.55.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$82	$89.75	$95	$97
Change	+17.90%	+29.04%	+36.59%	+39.47%

* Price targets were last updated on Aug 12, 2024.

Analyst Ratings

The average analyst rating for AstraZeneca stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	4	4	4	5	5	5
Buy	2	2	2	1	1	1
Hold	4	4	4	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Weston UBS	UBS	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Feb 13, 2025
Matthew Weston UBS	UBS	Strong Sell → Hold Upgrades n/a	Strong Sell → Hold	Upgrades	n/a	n/a	Nov 20, 2024
Hans Engel Erste Group	Erste Group	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Sep 11, 2024
Steve Scala TD Cowen	TD Cowen	Strong Buy Maintains $90 → $95	Strong Buy	Maintains	$90 → $95	+36.59%	Aug 12, 2024
Jasper Hellweg Argus Research	Argus Research	Strong Buy Maintains $80 → $85	Strong Buy	Maintains	$80 → $85	+22.21%	May 30, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

58.75B

from 54.07B

8.64%

from 54.07B

Revenue Next Year

62.34B

from 58.75B

6.11%

from 58.75B

EPS This Year

4.62

from 4.50

2.61%

from 4.50

EPS Next Year

5.24

from 4.62

13.40%

from 4.62

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	26.62B	37.42B	44.35B	45.81B	54.07B	58.75B	62.34B	66.02B
Revenue Growth	9.16%	40.58%	18.53%	3.29%	18.04%	8.64%	6.11%	5.90%
EPS	2.44	0.08	2.11	3.81	4.50	4.62	5.24	5.75
EPS Growth	137.39%	-96.76%	2,571.43%	80.57%	18.11%	2.61%	13.40%	9.77%
Forward PE	-	-	-	-	-	15.06	13.28	12.10
No. Analysts	-	-	-	-	-	28	29	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	62.6B	69.8B	76.4B
Avg	58.7B	62.3B	66.0B
Low	52.7B	54.8B	57.3B

Revenue Growth

Revenue Growth	2025	2026	2027
High	15.8%	18.9%	22.6%
Avg	8.6%	6.1%	5.9%
Low	-2.5%	-6.8%	-8.1%

EPS Forecast

EPS	2025	2026	2027
High	5.18	6.15	7.03
Avg	4.62	5.24	5.75
Low	3.74	4.35	4.66

EPS Growth

EPS Growth	2025	2026	2027
High	15.0%	33.1%	34.3%
Avg	2.6%	13.4%	9.8%
Low	-16.9%	-5.9%	-10.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.